Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2019-07-08 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, "Please read the full announcement in the attached PDF" and provides a link to a document titled "Transactions under Novozymes’ stock buyback program". This strongly indicates that the current document is an announcement about a transaction involving the company's own shares (a buyback program) rather than the detailed report itself. According to the 'MENU VS MEAL' rule, if the document is short and points to an attachment, it should be classified as an announcement. The most specific category for reporting the company buying back its own shares is 'Transaction in Own Shares' (POS).
2019-07-08 English
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is a corporate announcement, written in Danish, detailing transactions related to Novozymes' share buyback program ("Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram"). It provides specific daily transaction data (July 1st to July 5th, 2019) regarding the number of shares bought back and the total value. This content directly relates to the company purchasing its own shares. According to the definitions, the category for reporting the company buying back or selling its own shares is 'Transaction in Own Shares' (POS). The document is a detailed report/announcement of these transactions, not just a notice that a report is forthcoming (which would be RPA/RNS).
2019-07-08 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from Novozymes regarding their share buyback program. It details specific transactions conducted between June 24 and June 28, 2019, in accordance with the EU Market Abuse Regulation. It includes tables of transaction data, total shares repurchased, and contact information. This type of filing, which reports on the company's own share repurchases, is classified as 'Transaction in Own Shares'.
2019-07-01 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 98% confidence The document is a short announcement regarding Novozymes' share buyback program. It explicitly states 'Læs venligst hele meddelelsen i vedhæftede fil' (Please read the full announcement in the attached file) and provides a link to the actual report. Following the 'Menu vs Meal' rule, this is an announcement of a transaction rather than the detailed transaction report itself, and it specifically concerns the company buying back its own shares.
2019-07-01 Danish
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, "Please read the full announcement in the attached PDF" and provides a link to a document titled "2019_21_Stock_Buybackprogram_EN". This indicates the current document is an announcement about a report or transaction, not the full report itself. The content specifically concerns a 'stock buyback program'. According to the definitions, 'Transaction in Own Shares' (POS) covers the company buying back its own shares. Given the short length and the instruction to read the full announcement elsewhere, this is best classified as a Report Publication Announcement (RPA) or, more specifically, a POS announcement if the primary subject is the transaction itself. Since the subject is clearly the buyback program, POS is the most specific fit, but the 'MENU VS MEAL' rule suggests RPA if it's just announcing the availability of the details. However, POS is a specific transaction type, and this is the announcement of that transaction. Given the options, POS (Transaction in Own Shares) is the most accurate subject matter classification, even if it's a brief announcement.
2019-07-01 English
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document explicitly details 'Transactions under Novozymes' stock buyback program' for specific dates (June 24 to June 28, 2019) and provides detailed tables showing the number of shares purchased and the transaction value. This content directly relates to the company repurchasing its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses solely on share transactions.
2019-07-01 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.